←
Rik Lindeboom118 posts
Rik Lindeboom avatar

Rik Lindeboom

@RLindeboom

Group leader at Netherlands Cancer Institute / Quantitative Systems Biology

◷ Joined September 2011▧ 2 Photos and videos
Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·19 Nov 2024

Exciting news for aspiring PhD students: the NKI PhD Program 2025 will open soon for applications! We participate with multiple top labs in this prestigious program, which offers a unique opportunity for PhD candidates to engage in cutting-edge genome biology and cancer research.

📢 Applications for the NKI PhD program open from Jan 1 - Feb 28. Join our international research community in Amsterdam, working in cancer biology, AI research & life sciences with leading scientists and top facilities #PhD #CancerResearch More info: bit.ly/3O4bOjq

Post attachment
Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·29 Oct 2024

Passionate about doing innovative, curiosity-driven research and looking to start your own lab? The NKI has an opening for a Junior Group Leader position! Join us in our collaborative environment in Amsterdam, to use our state-of-the-art infrastructure to make a real impact.

👀 We're looking for a junior group leader! Join our innovative, curiosity-driven institute in a collaborative, international environment. Full freedom to pursue your research, competitive salary & relocation support. 📅 Apply by Dec 1 Info & application: bit.ly/3BLA3j8

Post attachment
Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·15 Aug 2024

Excited to share that we received the Technology Impact Award from @CancerResearch to develop methods to study immune - cancer cell interactions for identifying proteins and antigens that modulate cancer cell killing, and targets for immunotherapy! cancerresearch.org/cri-funde…

Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·19 Jun 2024

Highlights include the unexpected timing of the interferon response, new innate responses in unexpected cells and in abortive infections, identification and application of new activated T cell populations, and lower HLA-DQA2 expression as predictor for sustained infections. (3/4)

Post attachment
Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·19 Jun 2024

By applying single cell multiomics to a unique SARS-CoV-2 human challenge model, we uncovered the exact timeline of the local and systemic immune responses to viral exposure. This led to both fundamental and therapeutic insights into how our immune system works. (2/4)

Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·19 Jun 2024

Extremely excited to see our paper out in @Nature! How does the body respond to SARS-CoV-2, and what happens if you don't get infected after exposure? We unravel the exact timeline of the cellular responses to inoculation with SARS-CoV-2 in humans. (1/4) nature.com/articles/s41586-0…

Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·25 Mar 2024

Honored to be among the recipients of the NWO Open Competition M1 grant! We will develop tools to improve our understanding of TCR-antigen interactions, using high-throughput screening & AI. Stay tuned for a postdoc vacancy to join this exciting project! nwo.nl/en/news/nineteen-inno…

Rik Lindeboom avatar
Rik Lindeboom@RLindeboom·7 Mar 2024

Stoked to see this tour-the-force from the Bartke team out in Nature! We've decoded how DNA & histone modifications regulate protein binding to the genome using quantitative interaction proteomics. A leap forward in understanding chromatin dynamics! Congrats to everyone involved!

“If you want to know someone, look at their friends…” that’s how we decode histone codes and chromatin states. Finally, the dream has come true… Almost a decade after I started the project in London, it has been published on Nature. Enjoy the paper: nature.com/articles/s41586-0…

Post attachment